.Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03D_Progestogens.G03DB05_Demegestone.Demegestone .Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G03D_Progestogens.G03DB05_Demegestone.Demegestone| name: | Demegestone | |
| ATC code: | G03DB05 | route: | oral |
| compartments: | 1 | |
| dosage: | 2.5 | mg |
| volume of distribution: | 3.5 | L |
| clearance: | 35 | L/h |
| other parameters in model implementation | ||
Demegestone is a synthetic progestogen formerly used for the treatment of secondary amenorrhea, menopause-associated disorders, and in hormone replacement therapy. It acts as a progestin in the body and was withdrawn from market and is not currently approved for clinical use.
Estimated pharmacokinetic parameters based on class similarity to other orally administered progestins in healthy adult females. No published studies report direct demegestone pharmacokinetics.